Medical Care
In Vitro Diagnostics (IVD) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 550794
- Pages: 101
- Figures: 177
- Views: 1
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
The global market for In Vitro Diagnostics (IVD) was estimated to be worth US$ 919.9 million in 2023 and is forecast to a readjusted size of US$ 1530.1 million by 2030 with a CAGR of 7.4% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostics (IVD), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of In Vitro Diagnostics (IVD) by region & country, by Type, and by Application.
The In Vitro Diagnostics (IVD) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostics (IVD).
Market Segmentation
By Company
Pfizer
Thermo Fisher Scientific
Abbott
Biomerieux
Danaher Corporation
F. Hoffmann-La Roche
Becton Dickinson and Company
Bio-Rad Laboratories
Bayer AG
Sysmex Corporation
Johnson & Johnson
Hologic Inc
NEC Corp
Simens Healthcare
Segment by Type:
Reagents
Instruments
Software and Services
Segment by Application
Standalone Laboratory
Hospitals
Academic and Medical Schools
Point of Care Testing
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of In Vitro Diagnostics (IVD) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of In Vitro Diagnostics (IVD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of In Vitro Diagnostics (IVD) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for In Vitro Diagnostics (IVD) was estimated to be worth US$ 919.9 million in 2023 and is forecast to a readjusted size of US$ 1530.1 million by 2030 with a CAGR of 7.4% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostics (IVD), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of In Vitro Diagnostics (IVD) by region & country, by Type, and by Application.
The In Vitro Diagnostics (IVD) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostics (IVD).
Market Segmentation
By Company
Pfizer
Thermo Fisher Scientific
Abbott
Biomerieux
Danaher Corporation
F. Hoffmann-La Roche
Becton Dickinson and Company
Bio-Rad Laboratories
Bayer AG
Sysmex Corporation
Johnson & Johnson
Hologic Inc
NEC Corp
Simens Healthcare
Segment by Type:
Reagents
Instruments
Software and Services
Segment by Application
Standalone Laboratory
Hospitals
Academic and Medical Schools
Point of Care Testing
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of In Vitro Diagnostics (IVD) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of In Vitro Diagnostics (IVD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of In Vitro Diagnostics (IVD) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 In Vitro Diagnostics (IVD) Product Introduction
1.2 Global In Vitro Diagnostics (IVD) Market Size Forecast
1.3 In Vitro Diagnostics (IVD) Market Trends & Drivers
1.3.1 In Vitro Diagnostics (IVD) Industry Trends
1.3.2 In Vitro Diagnostics (IVD) Market Drivers & Opportunity
1.3.3 In Vitro Diagnostics (IVD) Market Challenges
1.3.4 In Vitro Diagnostics (IVD) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global In Vitro Diagnostics (IVD) Players Revenue Ranking (2023)
2.2 Global In Vitro Diagnostics (IVD) Revenue by Company (2019-2024)
2.3 Key Companies In Vitro Diagnostics (IVD) Manufacturing Base Distribution and Headquarters
2.4 Key Companies In Vitro Diagnostics (IVD) Product Offered
2.5 Key Companies Time to Begin Mass Production of In Vitro Diagnostics (IVD)
2.6 In Vitro Diagnostics (IVD) Market Competitive Analysis
2.6.1 In Vitro Diagnostics (IVD) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by In Vitro Diagnostics (IVD) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostics (IVD) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Reagents
3.1.2 Instruments
3.1.3 Software and Services
3.2 Global In Vitro Diagnostics (IVD) Sales Value by Type
3.2.1 Global In Vitro Diagnostics (IVD) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global In Vitro Diagnostics (IVD) Sales Value, by Type (2019-2030)
3.2.3 Global In Vitro Diagnostics (IVD) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Standalone Laboratory
4.1.2 Hospitals
4.1.3 Academic and Medical Schools
4.1.4 Point of Care Testing
4.1.5 Others
4.2 Global In Vitro Diagnostics (IVD) Sales Value by Application
4.2.1 Global In Vitro Diagnostics (IVD) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global In Vitro Diagnostics (IVD) Sales Value, by Application (2019-2030)
4.2.3 Global In Vitro Diagnostics (IVD) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global In Vitro Diagnostics (IVD) Sales Value by Region
5.1.1 Global In Vitro Diagnostics (IVD) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global In Vitro Diagnostics (IVD) Sales Value by Region (2019-2024)
5.1.3 Global In Vitro Diagnostics (IVD) Sales Value by Region (2025-2030)
5.1.4 Global In Vitro Diagnostics (IVD) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America In Vitro Diagnostics (IVD) Sales Value, 2019-2030
5.2.2 North America In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe In Vitro Diagnostics (IVD) Sales Value, 2019-2030
5.3.2 Europe In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific In Vitro Diagnostics (IVD) Sales Value, 2019-2030
5.4.2 Asia Pacific In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America In Vitro Diagnostics (IVD) Sales Value, 2019-2030
5.5.2 South America In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa In Vitro Diagnostics (IVD) Sales Value, 2019-2030
5.6.2 Middle East & Africa In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value
6.3 United States
6.3.1 United States In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.3.2 United States In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.4.2 Europe In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.5.2 China In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.5.3 China In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.6.2 Japan In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.7.2 South Korea In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.8.2 Southeast Asia In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.9.2 India In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.9.3 India In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer In Vitro Diagnostics (IVD) Products, Services and Solutions
7.1.4 Pfizer In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Products, Services and Solutions
7.2.4 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 Abbott
7.3.1 Abbott Profile
7.3.2 Abbott Main Business
7.3.3 Abbott In Vitro Diagnostics (IVD) Products, Services and Solutions
7.3.4 Abbott In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.3.5 Biomerieux Recent Developments
7.4 Biomerieux
7.4.1 Biomerieux Profile
7.4.2 Biomerieux Main Business
7.4.3 Biomerieux In Vitro Diagnostics (IVD) Products, Services and Solutions
7.4.4 Biomerieux In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.4.5 Biomerieux Recent Developments
7.5 Danaher Corporation
7.5.1 Danaher Corporation Profile
7.5.2 Danaher Corporation Main Business
7.5.3 Danaher Corporation In Vitro Diagnostics (IVD) Products, Services and Solutions
7.5.4 Danaher Corporation In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.5.5 Danaher Corporation Recent Developments
7.6 F. Hoffmann-La Roche
7.6.1 F. Hoffmann-La Roche Profile
7.6.2 F. Hoffmann-La Roche Main Business
7.6.3 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Products, Services and Solutions
7.6.4 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.6.5 F. Hoffmann-La Roche Recent Developments
7.7 Becton Dickinson and Company
7.7.1 Becton Dickinson and Company Profile
7.7.2 Becton Dickinson and Company Main Business
7.7.3 Becton Dickinson and Company In Vitro Diagnostics (IVD) Products, Services and Solutions
7.7.4 Becton Dickinson and Company In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.7.5 Becton Dickinson and Company Recent Developments
7.8 Bio-Rad Laboratories
7.8.1 Bio-Rad Laboratories Profile
7.8.2 Bio-Rad Laboratories Main Business
7.8.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Products, Services and Solutions
7.8.4 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.8.5 Bio-Rad Laboratories Recent Developments
7.9 Bayer AG
7.9.1 Bayer AG Profile
7.9.2 Bayer AG Main Business
7.9.3 Bayer AG In Vitro Diagnostics (IVD) Products, Services and Solutions
7.9.4 Bayer AG In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.9.5 Bayer AG Recent Developments
7.10 Sysmex Corporation
7.10.1 Sysmex Corporation Profile
7.10.2 Sysmex Corporation Main Business
7.10.3 Sysmex Corporation In Vitro Diagnostics (IVD) Products, Services and Solutions
7.10.4 Sysmex Corporation In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.10.5 Sysmex Corporation Recent Developments
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Profile
7.11.2 Johnson & Johnson Main Business
7.11.3 Johnson & Johnson In Vitro Diagnostics (IVD) Products, Services and Solutions
7.11.4 Johnson & Johnson In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.11.5 Johnson & Johnson Recent Developments
7.12 Hologic Inc
7.12.1 Hologic Inc Profile
7.12.2 Hologic Inc Main Business
7.12.3 Hologic Inc In Vitro Diagnostics (IVD) Products, Services and Solutions
7.12.4 Hologic Inc In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.12.5 Hologic Inc Recent Developments
7.13 NEC Corp
7.13.1 NEC Corp Profile
7.13.2 NEC Corp Main Business
7.13.3 NEC Corp In Vitro Diagnostics (IVD) Products, Services and Solutions
7.13.4 NEC Corp In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.13.5 NEC Corp Recent Developments
7.14 Simens Healthcare
7.14.1 Simens Healthcare Profile
7.14.2 Simens Healthcare Main Business
7.14.3 Simens Healthcare In Vitro Diagnostics (IVD) Products, Services and Solutions
7.14.4 Simens Healthcare In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.14.5 Simens Healthcare Recent Developments
8 Industry Chain Analysis
8.1 In Vitro Diagnostics (IVD) Industrial Chain
8.2 In Vitro Diagnostics (IVD) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 In Vitro Diagnostics (IVD) Sales Model
8.5.2 Sales Channel
8.5.3 In Vitro Diagnostics (IVD) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 In Vitro Diagnostics (IVD) Product Introduction
1.2 Global In Vitro Diagnostics (IVD) Market Size Forecast
1.3 In Vitro Diagnostics (IVD) Market Trends & Drivers
1.3.1 In Vitro Diagnostics (IVD) Industry Trends
1.3.2 In Vitro Diagnostics (IVD) Market Drivers & Opportunity
1.3.3 In Vitro Diagnostics (IVD) Market Challenges
1.3.4 In Vitro Diagnostics (IVD) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global In Vitro Diagnostics (IVD) Players Revenue Ranking (2023)
2.2 Global In Vitro Diagnostics (IVD) Revenue by Company (2019-2024)
2.3 Key Companies In Vitro Diagnostics (IVD) Manufacturing Base Distribution and Headquarters
2.4 Key Companies In Vitro Diagnostics (IVD) Product Offered
2.5 Key Companies Time to Begin Mass Production of In Vitro Diagnostics (IVD)
2.6 In Vitro Diagnostics (IVD) Market Competitive Analysis
2.6.1 In Vitro Diagnostics (IVD) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by In Vitro Diagnostics (IVD) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostics (IVD) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Reagents
3.1.2 Instruments
3.1.3 Software and Services
3.2 Global In Vitro Diagnostics (IVD) Sales Value by Type
3.2.1 Global In Vitro Diagnostics (IVD) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global In Vitro Diagnostics (IVD) Sales Value, by Type (2019-2030)
3.2.3 Global In Vitro Diagnostics (IVD) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Standalone Laboratory
4.1.2 Hospitals
4.1.3 Academic and Medical Schools
4.1.4 Point of Care Testing
4.1.5 Others
4.2 Global In Vitro Diagnostics (IVD) Sales Value by Application
4.2.1 Global In Vitro Diagnostics (IVD) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global In Vitro Diagnostics (IVD) Sales Value, by Application (2019-2030)
4.2.3 Global In Vitro Diagnostics (IVD) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global In Vitro Diagnostics (IVD) Sales Value by Region
5.1.1 Global In Vitro Diagnostics (IVD) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global In Vitro Diagnostics (IVD) Sales Value by Region (2019-2024)
5.1.3 Global In Vitro Diagnostics (IVD) Sales Value by Region (2025-2030)
5.1.4 Global In Vitro Diagnostics (IVD) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America In Vitro Diagnostics (IVD) Sales Value, 2019-2030
5.2.2 North America In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe In Vitro Diagnostics (IVD) Sales Value, 2019-2030
5.3.2 Europe In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific In Vitro Diagnostics (IVD) Sales Value, 2019-2030
5.4.2 Asia Pacific In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America In Vitro Diagnostics (IVD) Sales Value, 2019-2030
5.5.2 South America In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa In Vitro Diagnostics (IVD) Sales Value, 2019-2030
5.6.2 Middle East & Africa In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value
6.3 United States
6.3.1 United States In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.3.2 United States In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.4.2 Europe In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.5.2 China In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.5.3 China In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.6.2 Japan In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.7.2 South Korea In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.8.2 Southeast Asia In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India In Vitro Diagnostics (IVD) Sales Value, 2019-2030
6.9.2 India In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
6.9.3 India In Vitro Diagnostics (IVD) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer In Vitro Diagnostics (IVD) Products, Services and Solutions
7.1.4 Pfizer In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Products, Services and Solutions
7.2.4 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 Abbott
7.3.1 Abbott Profile
7.3.2 Abbott Main Business
7.3.3 Abbott In Vitro Diagnostics (IVD) Products, Services and Solutions
7.3.4 Abbott In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.3.5 Biomerieux Recent Developments
7.4 Biomerieux
7.4.1 Biomerieux Profile
7.4.2 Biomerieux Main Business
7.4.3 Biomerieux In Vitro Diagnostics (IVD) Products, Services and Solutions
7.4.4 Biomerieux In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.4.5 Biomerieux Recent Developments
7.5 Danaher Corporation
7.5.1 Danaher Corporation Profile
7.5.2 Danaher Corporation Main Business
7.5.3 Danaher Corporation In Vitro Diagnostics (IVD) Products, Services and Solutions
7.5.4 Danaher Corporation In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.5.5 Danaher Corporation Recent Developments
7.6 F. Hoffmann-La Roche
7.6.1 F. Hoffmann-La Roche Profile
7.6.2 F. Hoffmann-La Roche Main Business
7.6.3 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Products, Services and Solutions
7.6.4 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.6.5 F. Hoffmann-La Roche Recent Developments
7.7 Becton Dickinson and Company
7.7.1 Becton Dickinson and Company Profile
7.7.2 Becton Dickinson and Company Main Business
7.7.3 Becton Dickinson and Company In Vitro Diagnostics (IVD) Products, Services and Solutions
7.7.4 Becton Dickinson and Company In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.7.5 Becton Dickinson and Company Recent Developments
7.8 Bio-Rad Laboratories
7.8.1 Bio-Rad Laboratories Profile
7.8.2 Bio-Rad Laboratories Main Business
7.8.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Products, Services and Solutions
7.8.4 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.8.5 Bio-Rad Laboratories Recent Developments
7.9 Bayer AG
7.9.1 Bayer AG Profile
7.9.2 Bayer AG Main Business
7.9.3 Bayer AG In Vitro Diagnostics (IVD) Products, Services and Solutions
7.9.4 Bayer AG In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.9.5 Bayer AG Recent Developments
7.10 Sysmex Corporation
7.10.1 Sysmex Corporation Profile
7.10.2 Sysmex Corporation Main Business
7.10.3 Sysmex Corporation In Vitro Diagnostics (IVD) Products, Services and Solutions
7.10.4 Sysmex Corporation In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.10.5 Sysmex Corporation Recent Developments
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Profile
7.11.2 Johnson & Johnson Main Business
7.11.3 Johnson & Johnson In Vitro Diagnostics (IVD) Products, Services and Solutions
7.11.4 Johnson & Johnson In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.11.5 Johnson & Johnson Recent Developments
7.12 Hologic Inc
7.12.1 Hologic Inc Profile
7.12.2 Hologic Inc Main Business
7.12.3 Hologic Inc In Vitro Diagnostics (IVD) Products, Services and Solutions
7.12.4 Hologic Inc In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.12.5 Hologic Inc Recent Developments
7.13 NEC Corp
7.13.1 NEC Corp Profile
7.13.2 NEC Corp Main Business
7.13.3 NEC Corp In Vitro Diagnostics (IVD) Products, Services and Solutions
7.13.4 NEC Corp In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.13.5 NEC Corp Recent Developments
7.14 Simens Healthcare
7.14.1 Simens Healthcare Profile
7.14.2 Simens Healthcare Main Business
7.14.3 Simens Healthcare In Vitro Diagnostics (IVD) Products, Services and Solutions
7.14.4 Simens Healthcare In Vitro Diagnostics (IVD) Revenue (US$ Million) & (2019-2024)
7.14.5 Simens Healthcare Recent Developments
8 Industry Chain Analysis
8.1 In Vitro Diagnostics (IVD) Industrial Chain
8.2 In Vitro Diagnostics (IVD) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 In Vitro Diagnostics (IVD) Sales Model
8.5.2 Sales Channel
8.5.3 In Vitro Diagnostics (IVD) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. In Vitro Diagnostics (IVD) Market Trends
Table 2. In Vitro Diagnostics (IVD) Market Drivers & Opportunity
Table 3. In Vitro Diagnostics (IVD) Market Challenges
Table 4. In Vitro Diagnostics (IVD) Market Restraints
Table 5. Global In Vitro Diagnostics (IVD) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global In Vitro Diagnostics (IVD) Revenue Market Share by Company (2019-2024)
Table 7. Key Companies In Vitro Diagnostics (IVD) Manufacturing Base Distribution and Headquarters
Table 8. Key Companies In Vitro Diagnostics (IVD) Product Type
Table 9. Key Companies Time to Begin Mass Production of In Vitro Diagnostics (IVD)
Table 10. Global In Vitro Diagnostics (IVD) Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostics (IVD) as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global In Vitro Diagnostics (IVD) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global In Vitro Diagnostics (IVD) Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global In Vitro Diagnostics (IVD) Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global In Vitro Diagnostics (IVD) Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global In Vitro Diagnostics (IVD) Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global In Vitro Diagnostics (IVD) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global In Vitro Diagnostics (IVD) Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global In Vitro Diagnostics (IVD) Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global In Vitro Diagnostics (IVD) Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global In Vitro Diagnostics (IVD) Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global In Vitro Diagnostics (IVD) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global In Vitro Diagnostics (IVD) Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global In Vitro Diagnostics (IVD) Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global In Vitro Diagnostics (IVD) Sales Value by Region (2019-2024) & (%)
Table 27. Global In Vitro Diagnostics (IVD) Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value, (2025-2030) & (US$ Million)
Table 31. Pfizer Basic Information List
Table 32. Pfizer Description and Business Overview
Table 33. Pfizer In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 34. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Pfizer (2019-2024)
Table 35. Pfizer Recent Developments
Table 36. Thermo Fisher Scientific Basic Information List
Table 37. Thermo Fisher Scientific Description and Business Overview
Table 38. Thermo Fisher Scientific In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 39. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Thermo Fisher Scientific (2019-2024)
Table 40. Thermo Fisher Scientific Recent Developments
Table 41. Abbott Basic Information List
Table 42. Abbott Description and Business Overview
Table 43. Abbott In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 44. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Abbott (2019-2024)
Table 45. Abbott Recent Developments
Table 46. Biomerieux Basic Information List
Table 47. Biomerieux Description and Business Overview
Table 48. Biomerieux In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 49. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Biomerieux (2019-2024)
Table 50. Biomerieux Recent Developments
Table 51. Danaher Corporation Basic Information List
Table 52. Danaher Corporation Description and Business Overview
Table 53. Danaher Corporation In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 54. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Danaher Corporation (2019-2024)
Table 55. Danaher Corporation Recent Developments
Table 56. F. Hoffmann-La Roche Basic Information List
Table 57. F. Hoffmann-La Roche Description and Business Overview
Table 58. F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 59. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of F. Hoffmann-La Roche (2019-2024)
Table 60. F. Hoffmann-La Roche Recent Developments
Table 61. Becton Dickinson and Company Basic Information List
Table 62. Becton Dickinson and Company Description and Business Overview
Table 63. Becton Dickinson and Company In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 64. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Becton Dickinson and Company (2019-2024)
Table 65. Becton Dickinson and Company Recent Developments
Table 66. Bio-Rad Laboratories Basic Information List
Table 67. Bio-Rad Laboratories Description and Business Overview
Table 68. Bio-Rad Laboratories In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 69. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Bio-Rad Laboratories (2019-2024)
Table 70. Bio-Rad Laboratories Recent Developments
Table 71. Bayer AG Basic Information List
Table 72. Bayer AG Description and Business Overview
Table 73. Bayer AG In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 74. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Bayer AG (2019-2024)
Table 75. Bayer AG Recent Developments
Table 76. Sysmex Corporation Basic Information List
Table 77. Sysmex Corporation Description and Business Overview
Table 78. Sysmex Corporation In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 79. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Sysmex Corporation (2019-2024)
Table 80. Sysmex Corporation Recent Developments
Table 81. Johnson & Johnson Basic Information List
Table 82. Johnson & Johnson Description and Business Overview
Table 83. Johnson & Johnson In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 84. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Johnson & Johnson (2019-2024)
Table 85. Johnson & Johnson Recent Developments
Table 86. Hologic Inc Basic Information List
Table 87. Hologic Inc Description and Business Overview
Table 88. Hologic Inc In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 89. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Hologic Inc (2019-2024)
Table 90. Hologic Inc Recent Developments
Table 91. NEC Corp Basic Information List
Table 92. NEC Corp Description and Business Overview
Table 93. NEC Corp In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 94. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of NEC Corp (2019-2024)
Table 95. NEC Corp Recent Developments
Table 96. Simens Healthcare Basic Information List
Table 97. Simens Healthcare Description and Business Overview
Table 98. Simens Healthcare In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 99. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Simens Healthcare (2019-2024)
Table 100. Simens Healthcare Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. In Vitro Diagnostics (IVD) Downstream Customers
Table 104. In Vitro Diagnostics (IVD) Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. In Vitro Diagnostics (IVD) Product Picture
Figure 2. Global In Vitro Diagnostics (IVD) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 4. In Vitro Diagnostics (IVD) Report Years Considered
Figure 5. Global In Vitro Diagnostics (IVD) Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by In Vitro Diagnostics (IVD) Revenue in 2023
Figure 7. In Vitro Diagnostics (IVD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Reagents Picture
Figure 9. Instruments Picture
Figure 10. Software and Services Picture
Figure 11. Global In Vitro Diagnostics (IVD) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global In Vitro Diagnostics (IVD) Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Standalone Laboratory
Figure 14. Product Picture of Hospitals
Figure 15. Product Picture of Academic and Medical Schools
Figure 16. Product Picture of Point of Care Testing
Figure 17. Product Picture of Others
Figure 18. Global In Vitro Diagnostics (IVD) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global In Vitro Diagnostics (IVD) Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 21. North America In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
Figure 26. South America In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 27. South America In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value (%), (2019-2030)
Figure 31. United States In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 33. United States In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 37. China In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 38. China In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 39. China In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 49. India In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 50. India In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 51. India In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 52. In Vitro Diagnostics (IVD) Industrial Chain
Figure 53. In Vitro Diagnostics (IVD) Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Table 1. In Vitro Diagnostics (IVD) Market Trends
Table 2. In Vitro Diagnostics (IVD) Market Drivers & Opportunity
Table 3. In Vitro Diagnostics (IVD) Market Challenges
Table 4. In Vitro Diagnostics (IVD) Market Restraints
Table 5. Global In Vitro Diagnostics (IVD) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global In Vitro Diagnostics (IVD) Revenue Market Share by Company (2019-2024)
Table 7. Key Companies In Vitro Diagnostics (IVD) Manufacturing Base Distribution and Headquarters
Table 8. Key Companies In Vitro Diagnostics (IVD) Product Type
Table 9. Key Companies Time to Begin Mass Production of In Vitro Diagnostics (IVD)
Table 10. Global In Vitro Diagnostics (IVD) Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostics (IVD) as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global In Vitro Diagnostics (IVD) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global In Vitro Diagnostics (IVD) Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global In Vitro Diagnostics (IVD) Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global In Vitro Diagnostics (IVD) Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global In Vitro Diagnostics (IVD) Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global In Vitro Diagnostics (IVD) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global In Vitro Diagnostics (IVD) Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global In Vitro Diagnostics (IVD) Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global In Vitro Diagnostics (IVD) Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global In Vitro Diagnostics (IVD) Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global In Vitro Diagnostics (IVD) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global In Vitro Diagnostics (IVD) Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global In Vitro Diagnostics (IVD) Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global In Vitro Diagnostics (IVD) Sales Value by Region (2019-2024) & (%)
Table 27. Global In Vitro Diagnostics (IVD) Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value, (2025-2030) & (US$ Million)
Table 31. Pfizer Basic Information List
Table 32. Pfizer Description and Business Overview
Table 33. Pfizer In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 34. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Pfizer (2019-2024)
Table 35. Pfizer Recent Developments
Table 36. Thermo Fisher Scientific Basic Information List
Table 37. Thermo Fisher Scientific Description and Business Overview
Table 38. Thermo Fisher Scientific In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 39. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Thermo Fisher Scientific (2019-2024)
Table 40. Thermo Fisher Scientific Recent Developments
Table 41. Abbott Basic Information List
Table 42. Abbott Description and Business Overview
Table 43. Abbott In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 44. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Abbott (2019-2024)
Table 45. Abbott Recent Developments
Table 46. Biomerieux Basic Information List
Table 47. Biomerieux Description and Business Overview
Table 48. Biomerieux In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 49. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Biomerieux (2019-2024)
Table 50. Biomerieux Recent Developments
Table 51. Danaher Corporation Basic Information List
Table 52. Danaher Corporation Description and Business Overview
Table 53. Danaher Corporation In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 54. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Danaher Corporation (2019-2024)
Table 55. Danaher Corporation Recent Developments
Table 56. F. Hoffmann-La Roche Basic Information List
Table 57. F. Hoffmann-La Roche Description and Business Overview
Table 58. F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 59. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of F. Hoffmann-La Roche (2019-2024)
Table 60. F. Hoffmann-La Roche Recent Developments
Table 61. Becton Dickinson and Company Basic Information List
Table 62. Becton Dickinson and Company Description and Business Overview
Table 63. Becton Dickinson and Company In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 64. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Becton Dickinson and Company (2019-2024)
Table 65. Becton Dickinson and Company Recent Developments
Table 66. Bio-Rad Laboratories Basic Information List
Table 67. Bio-Rad Laboratories Description and Business Overview
Table 68. Bio-Rad Laboratories In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 69. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Bio-Rad Laboratories (2019-2024)
Table 70. Bio-Rad Laboratories Recent Developments
Table 71. Bayer AG Basic Information List
Table 72. Bayer AG Description and Business Overview
Table 73. Bayer AG In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 74. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Bayer AG (2019-2024)
Table 75. Bayer AG Recent Developments
Table 76. Sysmex Corporation Basic Information List
Table 77. Sysmex Corporation Description and Business Overview
Table 78. Sysmex Corporation In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 79. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Sysmex Corporation (2019-2024)
Table 80. Sysmex Corporation Recent Developments
Table 81. Johnson & Johnson Basic Information List
Table 82. Johnson & Johnson Description and Business Overview
Table 83. Johnson & Johnson In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 84. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Johnson & Johnson (2019-2024)
Table 85. Johnson & Johnson Recent Developments
Table 86. Hologic Inc Basic Information List
Table 87. Hologic Inc Description and Business Overview
Table 88. Hologic Inc In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 89. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Hologic Inc (2019-2024)
Table 90. Hologic Inc Recent Developments
Table 91. NEC Corp Basic Information List
Table 92. NEC Corp Description and Business Overview
Table 93. NEC Corp In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 94. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of NEC Corp (2019-2024)
Table 95. NEC Corp Recent Developments
Table 96. Simens Healthcare Basic Information List
Table 97. Simens Healthcare Description and Business Overview
Table 98. Simens Healthcare In Vitro Diagnostics (IVD) Products, Services and Solutions
Table 99. Revenue (US$ Million) in In Vitro Diagnostics (IVD) Business of Simens Healthcare (2019-2024)
Table 100. Simens Healthcare Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. In Vitro Diagnostics (IVD) Downstream Customers
Table 104. In Vitro Diagnostics (IVD) Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. In Vitro Diagnostics (IVD) Product Picture
Figure 2. Global In Vitro Diagnostics (IVD) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 4. In Vitro Diagnostics (IVD) Report Years Considered
Figure 5. Global In Vitro Diagnostics (IVD) Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by In Vitro Diagnostics (IVD) Revenue in 2023
Figure 7. In Vitro Diagnostics (IVD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Reagents Picture
Figure 9. Instruments Picture
Figure 10. Software and Services Picture
Figure 11. Global In Vitro Diagnostics (IVD) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global In Vitro Diagnostics (IVD) Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Standalone Laboratory
Figure 14. Product Picture of Hospitals
Figure 15. Product Picture of Academic and Medical Schools
Figure 16. Product Picture of Point of Care Testing
Figure 17. Product Picture of Others
Figure 18. Global In Vitro Diagnostics (IVD) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global In Vitro Diagnostics (IVD) Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 21. North America In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
Figure 26. South America In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 27. South America In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa In Vitro Diagnostics (IVD) Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa In Vitro Diagnostics (IVD) Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions In Vitro Diagnostics (IVD) Sales Value (%), (2019-2030)
Figure 31. United States In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 33. United States In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 37. China In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 38. China In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 39. China In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 49. India In Vitro Diagnostics (IVD) Sales Value, (2019-2030) & (US$ Million)
Figure 50. India In Vitro Diagnostics (IVD) Sales Value by Type (%), 2023 VS 2030
Figure 51. India In Vitro Diagnostics (IVD) Sales Value by Application (%), 2023 VS 2030
Figure 52. In Vitro Diagnostics (IVD) Industrial Chain
Figure 53. In Vitro Diagnostics (IVD) Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232